RE:RE:RE:Funny Boardlol, no chance BioSteel comes close to Aphria's revenue. BioSteel does about 2M per Q, not even close. Canopy is a terrible company. Declining revenues, hundereds of Millions in losses, probably the worst quality cannabis in the market. Their drinks aren't even the best. Their costs are so high they have zero path to profitiability. There is a reason they are interested in buying Aphria. Unfortunately for Aphria's shareholders, Aphria's C-Suite is clueless.
Homestretch4me wrote: Irishcanuck, I'm embarrassed for you. Do you have any basic math skills? Aphria had 17.5 million of EBITDA in 2020. At that rate it will take 145 years to get the resources Canopy has right now. When Constellation buys the second tranche of shares from Canopy, it will only take 428 years for Aphria to rival Canopy's resources. The purchase of the second tranche of shares will likely happen in 2021 or 2022. What that means is you and four more generations of your family and mine will be long dead before this happens.
For you and people like you that don't know anything about the industry you are invested in I'm sure you all believe that Aphria's management team is better than Constellations management team. You do know that Constellation is in full control of Canopy right? David Klein is the former CFO of Constellation and was hand picked by Constellation to be the CEO for Canopy. Constellation also holds 4 of the 7 board seats at Canopy so when you are comparing Aphria's management to Canopy's you are actually comparing Aphria's management to Constellation's. That's what makes you and everything you say a joke. I am certain that inside of 2 years, Biosteel and Biosteel alone will dwarf Aphrias revenues nevermind all the other channels Canopy has.
As far as your statement claiming Canopy is not structured, that is the claim of someone that doesn't understand what they are looking at. Canopy's organization is so complex and diverse I suggest you stop trying to understand it. You just don't have the business acumen to understand it.
Tell you what. How about you explain to me and everyone else on this board what Aphria's strategy for entering the US market is and how Sweetwater fits into those plans. Please keep in mind and provide an explanations on how Aphria plans to address their glaring lack of any, and by any I mean zero, licenses in the US to enter the Cannabis industry. Where will Aphria get the money to make significant investments in the US? EBITDA of 17.5 million a year won't help much. I guess that means more debt and dilution for Aphria Shareholders. Canopy doesn't have debt or dilution issues(see above comments on cash position)
I'm really looking forward on your comments in regards to Aphria's US plans as I'm sure everyone else on this board is as well. I'll wait right here. I think the sound of the crickets will be deafening.
IrishCanuck wrote: Your block of text is a lot like Canopy business plans... a lot of ideas thrown together but not structured.
No one talks about Tweed or other brands is because it's a dust product so congrats on selling some upfront then not getting many renewed customers. Aphria sells more than Canopy in Canada already because of this. The product you are selling is not as simple as coca-cola so there is no point shoving Tweed in everyone's face when different markets will want different products.
When Canopy takes over Acreage, Constellation wins, not you as a small potatoes investor. There is a lot of growth needed to fill that 10 billion market cap sized shoes as it stands already. And to Acreage's board, they'll line their pockets before yours too so keep cheerleading your high priced celebrities.
Canopy has spent so much money for a business plan that may not come to fruition because legislation hasn't even been proposed let alone passed. Aphria has been patient as they've always outlined and will generate a coherent business plan when rules and regulations are set up. You have such a high fixed cost overhead already you may get into states quickly but you will not be able to maneuver. Aphria is already free cash flow positive and growing meaning their war chest is accumulating.
I'll let this article finish my last points but most importantly Canopy can be 4 YEARS away from profits! Enjoy your share dilution
https://www.fool.com/investing/2020/11/05/3-pot-stocks-to-avoid-like-the-plague-in-november/